Companies Dominating the Lipase Reagent Landscape
- DIALAB
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- DiaSys Diagnostic Systems GmbH
- Sunson Industry Group Co., Ltd
- Randox Laboratories Ltd.
- Abbott, Beckman Coulter, Inc.
- Biocompare,
- VitroScient
- Merck Group
- Sisco Research Laboratories Pvt. Ltd.
- BioSystems
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of lipase reagent is estimated at USD 802.88 billion.
The lipase reagent market size was valued at USD 721.08 billion in 2024 and is likely to cross USD 1.71 trillion by 2037, expanding at more than 6.9% CAGR during the forecast period i.e., between 2025-2037. Increasing gastrointestinal issues and rising concern for diagnosis will boost the market growth.
North America industry is set to hold largest revenue share of 36% by 2037, on the back of increasing concern among people about complications related to gastrointestinal tract.
The major players in the market are DIALAB, DiaSys Diagnostic Systems GmbH, Sunson Industry Group Co., Ltd, Randox Laboratories Ltd., Abbott, Beckman Coulter, Inc., Biocompare, VitroScient, Merck Group, Sisco Research Laboratories Pvt. Ltd., BioSystems
